This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2011-2013.
Company Filing History:
Years Active: 2011-2013
Title: Kristin M Listner: Innovator in Plasmid DNA Production
Introduction
Kristin M Listner is a prominent inventor based in East Windsor, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the production of plasmid DNA. With a total of 2 patents to her name, her work has the potential to impact pharmaceutical applications significantly.
Latest Patents
Kristin's latest patents focus on methods for increasing the yield of plasmid DNA production. The first patent describes a method that involves selecting a highly productive clonal subtype of a strain, including but not limited to the DH5 strain, which harbors a DNA plasmid. This method cultivates the clonal subtype using fed-batch fermentation in a chemically-defined medium. The process can generate record quantities of plasmid DNA when cultivated on an industrial scale. This innovative method is particularly useful for producing pharmaceutical-grade DNA for polynucleotide vaccination and gene therapy treatment regimens.
Career Highlights
Kristin M Listner is currently employed at Merck Sharp & Dohme Corporation, where she continues to advance her research in biotechnology. Her work is instrumental in developing efficient methods for DNA production, which is crucial for various medical applications.
Collaborations
Some of her notable coworkers include Michel M Chartrain and Laura Kizer Bentley, who contribute to her innovative projects and research endeavors.
Conclusion
Kristin M Listner is a key figure in the field of plasmid DNA production, with her patents paving the way for advancements in biotechnology and pharmaceutical applications. Her contributions are vital for the future of gene therapy and vaccination strategies.